Axsome Therapeutics, Inc. (AXSM) insider trading.
In Q3 2026, insiders at Axsome Therapeutics, Inc. reported 8 non-derivative transactions on 3 Forms 3, 4 and 5: 0 open-market purchases and 4 sales worth $24.6M.
- Transactions
- 8
- Purchases (P)
- 0
- Sales (S)
- 4
- Net shares, P minus S
- -109,330
- Insiders
- 2
- Last filed
- 2026-09-03
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Tabuteau Herriot | Director, Officer, TenPercentOwner · Chief Executive Officer | 6 | 0 | 3 |
| Jacobson Mark L. | Officer · Chief Operating Officer | 2 | 0 | 1 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-03 | Jacobson Mark L. | S (D) | 10,000 | $208.65 | 0 | Form 4 |
| 2026-09-03 | Jacobson Mark L. | M (A) | 10,000 | $12.95 | 10,000 | Form 4 |
| 2026-08-06 | Tabuteau Herriot | S (D) | 4,660 | $213.95 | 7,229 | Form 4 |
| 2026-08-06 | Tabuteau Herriot | M (A) | 4,660 | $4.95 | 11,889 | Form 4 |
| 2026-08-05 | Tabuteau Herriot | S (D) | 45,004 | $212.01 | 7,229 | Form 4 |
| 2026-08-05 | Tabuteau Herriot | M (A) | 45,004 | $4.95 | 52,233 | Form 4 |
| 2026-07-01 | Tabuteau Herriot | M (A) | 49,666 | $4.95 | 56,895 | Form 4 |
| 2026-07-01 | Tabuteau Herriot | S (D) | 49,666 | $240.25 | 7,229 | Form 4 |
Transaction codes in this quarter
Get AXSM insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1579428&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · AXSM company page · Axsome Therapeutics, Inc. on SEC.gov
Questions
Are insiders buying or selling Axsome Therapeutics, Inc. (AXSM)?
In Q3 2026, insiders at Axsome Therapeutics, Inc. reported 8 non-derivative transactions on 3 Forms 3, 4 and 5: 0 open-market purchases and 4 sales worth $24.6M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Axsome Therapeutics, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/axsm.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.